Linked Life Data

17653829

Source:http://linkedlifedata.com/resource/pubmed/id/17653829

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2007-8-9
pubmed:abstractText
It is unknown whether postmenopausal unopposed estrogen users are better off, in terms of endometrial cancer risk, switching to a combined estrogen-progestin regimen or stopping hormone use altogether.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0957-5243
pubmed:author
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1001-7
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy.
pubmed:affiliation
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98195, USA. jchubak@u.washington.edu
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural